Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Bayer hires law firm to investigate Monsanto stakeholder file issue

Published 12/05/2019, 16:06
Updated 12/05/2019, 16:06
© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen

© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen

By Patricia Weiss and Ludwig Burger

FRANKFURT (Reuters) - Bayer (DE:BAYGN) said on Sunday it was hiring an external law firm to investigate French media complaints that Monsanto (NYSE:MON), the U.S. seed maker it took over last year, had compiled a file of influential personalities.

The German life sciences and pharmaceuticals group said that, following an internal review, it understood that this initiative had raised concerns and criticism.

"This is not the way Bayer seeks dialogue with society and stakeholders. We apologise for this behaviour," Bayer said in a statement. It added, however, that there was no indication that compiling the lists was illegal.

French prosecutors opened an inquiry on Friday after newspaper Le Monde filed a complaint alleging that Monsanto had compiled a file of 200 names, including journalists and lawmakers, in the hope of influencing their positions on pesticides.

The French investigation is the latest fallout from Bayer's $63 billion (48.49 billion pounds) takeover of Monsanto. It already faces potentially heavy costs from U.S. class-action lawsuits in which plaintiffs argue that its Roundup weedkiller causes cancer.

Bayer shares have shed more than 40 percent since a first adverse U.S. judgment on Roundup last August, leaving the company with a market capitalisation smaller than the price it paid for Monsanto.

Shareholders delivered a rare rebuke to CEO Werner Baumann's management team at Bayer's annual general meeting last month, with a majority voting against ratifying the executive board's business conduct in 2018.

Commenting on the French allegations, Bayer said its law firm would inform all of the individuals on the Monsanto list about the information collected about them. Bayer would also "fully support" the French prosecutor's investigation.

Matthias Berninger, Bayer's new head of public and government affairs, would evaluate the matter internally and assess the behaviour of people involved, both inside and outside the company.

"Our highest priority is to create transparency," Bayer said, adding that the Monsanto manager responsible for the issue had left the company soon after the takeover.

"Bayer stands for openness and fair dealings with all interest groups," it added.

© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen

"We do not tolerate unethical behaviour in our company. Of course, this also applies to data protection regulations in all jurisdictions in which we operate."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.